(Updates with response by attorney general’s spokesman in fourth paragraph.)
Nov. 4 (Bloomberg) -- Allergan Inc., the maker of Botox, has been asked by the Massachusetts attorney general to provide documents on its eye-care group, according to a regulatory filing.
The Medicare Fraud Division of the attorney general’s office requested the information relating to Allergan’s Eye Care Business Advisor Group, Allergan Access and BSM Connect for Ophthalmology, according to a regulatory filing today.
The company, based in Irvine, California, said it received a so-called civil investigative demand in September.
“It is our office policy to neither confirm nor deny investigations,” Grant Woodman, a spokesman for Massachusetts Attorney General Martha Coakley, said in a telephone interview.
Allergan made $2.3 billion from sales of its eye care pharmaceuticals, accounting for 47 percent of its total revenue last year.
--With assistance by Don Jeffrey in New York. Editors: Chris Staiti, Fred Strasser
--Editors: Fred Strasser, Michael Hytha
To contact the reporter on this story: Elizabeth Lopatto in New York at firstname.lastname@example.org.
To contact the editor responsible for this story: Reg Gale at email@example.com.